OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Letter to John II. Hammergren, Chief Executive Officer of McKesson - Drug Prices Remain High Despite Trump Administration's Promises of "Voluntary, Massive Drops" in Prices

Letter

Date: June 29, 2018
Issues: Business and Consumers Executive Branch Health and Health Care

Only available in PDF Format, please view source for document.


Source
arrow_upward